Key Points
- Globe Life CEO Frank Svoboda sold 12,500 shares on Feb. 17 at an average price of $144.78 for about $1.81M, cutting his ownership by 25.84% to 35,868 shares per an SEC Form 4 filing.
- The company slightly missed quarterly expectations, reporting $3.39 EPS vs. $3.44 expected and $1.52B in revenue vs. $1.53B, and issued FY2026 guidance of $14.95–$15.65 EPS.
- Analysts remain largely positive with a consensus "Moderate Buy" and $171.22 target; the stock trades at a ~10.2 PE and $11.45B market cap, is down about 1.5% on the news, and is 81.61% institutionally owned.
Globe Life Inc. (NYSE:GL - Get Free Report) CEO Frank Svoboda sold 12,500 shares of the firm's stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total value of $1,809,750.00. Following the completion of the sale, the chief executive officer directly owned 35,868 shares of the company's stock, valued at $5,192,969.04. This represents a 25.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Globe Life Stock Down 1.5%
Shares of NYSE GL opened at $143.79 on Thursday. The company has a debt-to-equity ratio of 0.41, a current ratio of 0.07 and a quick ratio of 0.07. The stock has a market capitalization of $11.45 billion, a PE ratio of 10.21 and a beta of 0.47. Globe Life Inc. has a one year low of $109.38 and a one year high of $152.71. The business's fifty day moving average price is $141.23 and its 200-day moving average price is $138.52.
Globe Life (NYSE:GL - Get Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.44 by ($0.05). The firm had revenue of $1.52 billion during the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The company's revenue was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities research analysts anticipate that Globe Life Inc. will post 13.87 EPS for the current year.
Institutional Investors Weigh In On Globe Life
Several large investors have recently added to or reduced their stakes in GL. Transcend Capital Advisors LLC increased its stake in Globe Life by 3.9% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company's stock worth $317,000 after acquiring an additional 84 shares during the last quarter. Natural Investments LLC grew its holdings in shares of Globe Life by 2.6% during the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company's stock worth $482,000 after purchasing an additional 87 shares in the last quarter. Parallel Advisors LLC grew its holdings in shares of Globe Life by 5.6% during the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company's stock worth $231,000 after purchasing an additional 87 shares in the last quarter. Intech Investment Management LLC increased its position in shares of Globe Life by 0.8% in the second quarter. Intech Investment Management LLC now owns 11,572 shares of the company's stock worth $1,438,000 after purchasing an additional 95 shares during the last quarter. Finally, CX Institutional raised its stake in Globe Life by 5.6% in the third quarter. CX Institutional now owns 1,805 shares of the company's stock valued at $258,000 after purchasing an additional 96 shares in the last quarter. Institutional investors own 81.61% of the company's stock.
Wall Street Analyst Weigh In
GL has been the subject of several analyst reports. TD Cowen reaffirmed a "buy" rating on shares of Globe Life in a report on Thursday, December 11th. Morgan Stanley reaffirmed an "overweight" rating and issued a $176.00 price target on shares of Globe Life in a report on Monday, December 15th. Wells Fargo & Company reduced their price target on Globe Life from $172.00 to $170.00 and set an "overweight" rating for the company in a research report on Friday, October 24th. JPMorgan Chase & Co. increased their price objective on Globe Life from $180.00 to $181.00 and gave the stock an "overweight" rating in a report on Thursday, February 5th. Finally, Truist Financial lifted their target price on Globe Life from $158.00 to $180.00 and gave the company a "buy" rating in a report on Friday, February 6th. Eight research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $171.22.
View Our Latest Report on GL
About Globe Life
(
Get Free Report)
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
